Yaashini Rajasegaran

Ms. Yaashini Rajasegaran

Advanced Medical and Dental Institue, Universiti Sains Malaysia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2021 in Genes
Verified
Journal Article
Open access
PDF file
YMYik Mot
Yik Mot
AAAdam Azlan
Adam Azlan
YRYaashini Rajasegaran
Yaashini Rajasegaran
ARAliaa Rosli
Aliaa Rosli
NYNarazah Mohd Yusoff
Narazah Mohd Yusoff
Emmanuel Jairaj MosesEmmanuel Jairaj Moses
Emmanuel Jairaj Moses
The proliferative capacity and continuous survival of cells are highly dependent on telomerase expression and the maintenance of telomere length. For this reason, elevated expression of telomerase has been identified in virtually all cancers, including leukemias; however, it should be noted that expression of telomerase is sometimes observed later in malignant development. This time point of activation is highly dependent on the type of leukemia and its causative factors. Many recent studies in this field have contributed to the elucidation of the mechanisms by which the various forms of leukemias increase telomerase activity. These include the dysregulation of telomerase reverse transcriptase (TERT) at various levels which include transcriptional, post-transcriptional, and post-translational stages. The pathways and biological molecules involved in these processes are also being deciphered with the advent of enabling technologies such as next-generation sequencing (NGS), ribonucleic acid sequencing (RNA-Seq), liquid chromatography-mass spectrometry (LCMS/MS), and many others. It has also been established that TERT possess diagnostic value as most adult cells do not express high levels of telomerase. Indeed, studies have shown that prognosis is not favorable in patients who have leukemias expressing high levels of telomerase. Recent research has indicated that targeting of this gene is able to control the survival of malignant cells and therefore offers a potential treatment for TERT-dependent leukemias. Here we review the mechanisms of hTERT regulation and deliberate their association in malignant states of leukemic cells. Further, we also cover the clinical implications of this gene including its use in diagnostic, prognostic, and therapeutic discoveries.

19 October 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
YRYaashini Rajasegaran
Yaashini Rajasegaran
AAAdam Azlan
Adam Azlan
ARAliaa Arina Rosli
Aliaa Arina Rosli
YMYik Mot
Yik Mot
KZKhor Kang Zi
Khor Kang Zi
Emmanuel Jairaj MosesEmmanuel Jairaj Moses
Emmanuel Jairaj Moses
MicroRNAs (miRNAs) are short non-coding RNAs involved in post-transcriptional gene regulation. Over the past years, various studies have demonstrated the role of aberrant miRNA expression in the onset of cancer. The mechanisms by which miRNA exerts its cancer-promoting or inhibitory effects are apparent through the various cancer hallmarks, which include selective proliferative advantage, altered stress response, vascularization, invasion and metastasis, metabolic rewiring, the tumor microenvironment and immune modulation; therefore, this review aims to highlight the association between miRNAs and the various cancer hallmarks by dissecting the mechanisms of miRNA regulation in each hallmark separately. It is hoped that the information presented herein will provide further insights regarding the role of cancer and serve as a guideline to evaluate the potential of microRNAs to be utilized as biomarkers and therapeutic targets on a larger scale in cancer research.

15 April 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
AAAdam Azlan
Adam Azlan
YRYaashini Rajasegaran
Yaashini Rajasegaran
KZKhor Kang Zi
Khor Kang Zi
ARAliaa Arina Rosli
Aliaa Arina Rosli
YMYik Mot
Yik Mot
Emmanuel Jairaj MosesEmmanuel Jairaj Moses
Emmanuel Jairaj Moses
Micro-RNA (miRNAs) are short non-coding RNAs of about 18–20 nucleotides in length and are implicated in many cellular processes including proliferation, development, differentiation, apoptosis and cell signaling. Furthermore, it is well known that miRNA expression is frequently dysregulated in many cancers. Therefore, this review will highlight the various mechanisms by which microRNAs are dysregulated in cancer. Further highlights include the abundance of molecular genetics tools that are currently available to study miRNA function as well as their advantages and disadvantages with a special focus on various CRISPR/Cas systems This review provides general workflows and some practical considerations when studying miRNA function thus enabling researchers to make informed decisions in regards to the appropriate molecular genetics tool to be utilized for their experiments.

13 October 2022 in Clinical and Experimental Medicine
Verified
Journal Article
Closed access
PDF file
ARAliaa Arina Rosli
Aliaa Arina Rosli
AAAdam Azlan
Adam Azlan
YRYaashini Rajasegaran
Yaashini Rajasegaran
YMYik Mot
Yik Mot
OHOlaf Heidenreich
Olaf Heidenreich
Emmanuel Jairaj MosesEmmanuel Jairaj Moses
Emmanuel Jairaj Moses